Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus vs MMF for HCV Fibrosis After Liver Transplant
NCT01707849Phase 3Completed
- Sponsor
- Vall d'Hebron University Hospital
- Start
- Oct 2012
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in hepatitis C (HCV), Liver Fibrosis (LF), sponsored by Vall d'Hebron University Hospital. Started Oct 2012; status: completed.
02
Drugs
everolimus
03
Conditions
hepatitis C (HCV)Liver Fibrosis (LF)
Beyond the preview
Go deeper on NCT01707849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01707849.